According to the Wise Finance app, shares of Codi-B (02487) rose more than 5% in early trading, and as of the time of publication, they have increased by 3.87%, to HKD 12.34, with a turnover of HKD 2.3564 million.

On the news front, Codi recently released its mid-term performance, with the Group's income reaching RMB 95.575 million, a year-on-year increase of 178.3%; the parent company's net loss attributable to shareholders decreased by 87.75% to RMB 0.201 billion. Sun Hung Kai Securities pointed out that Ouma's skincare revenue in the first half of the year was RMB 47 million, accounting for nearly 50% of the total volume; pipeline progress exceeded expectations; the company plans to implement a share buyback, with related funds not exceeding HKD 54.7 million, demonstrating the company's long-term confidence in development; the latest Hang Seng Index adjustment still includes Codi, with no risk of delisting within 2024.

Lyon released a research report stating that 2025 is a crucial business year for Codi, as it is expected to launch three core products, CU-40102, CU-10201, and CU-30101, one after another in the next 12 months. The unique positioning and first-mover advantages of these products are expected to support index-level growth prospects.